Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Increases in community-acquired infections caused by extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae have important implications for hospital infection control and empirical antibiotic therapy protocols. We developed and validated a tool for identifying patients harboring these organisms at hospital admission. We retrospectively analyzed chart data for 849 adult inpatients. The derivation cohort included 339 patients admitted to a large hospital in Rome during 2008, with ( n = 113) or without ( n = 226) culture positivity for ESBL-producing Escherichia coli , Klebsiella spp., or Proteus mirabilis within 48 h after admission. Logistic-regression-based prediction scores were calculated based on variables independently associated with the outcome. The model was validated in a second cohort ( n = 510) selected with identical criteria in hospitals in Genoa and Turin during 2009. Prediction scores were based on the following six variables (reported with odds ratio for study outcome and the 95% confidence intervals in brackets): recent (≤12 months before admission) hospitalization (5.69 [2.94 to 10.99]), transfer from another health care facility (5.61 [1.65 to 19.08]), Charlson comorbidity score ≥ 4 (3.80 [1.90 to 7.59]), recent (≤3 months before admission) β-lactam and/or fluoroquinolone treatment (3.68 [1.96 to 6.91]), recent urinary catheterization (3.52 [1.96 to 6.91]), and age ≥ 70 years (3.20 [1.79 to 5.70]). The model displayed good calibration and good-to-excellent discrimination in the derivation and validation sets (Hosmer-Lemshow χ 2 = 15.28 and 14.07; P = 0.17 and 0.23; areas under the receiver-operating characteristic curve, 0.83 and 0.92). It reliably identified patients likely to be harboring ESBL-producing Enterobacteriaceae at hospital admission who may need special infection control measures. Further study is needed to confirm this model's potential as a guide for prescribing empirical antibiotic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“morbidities was determined based on the Charlson comorbidity index (5).”
MethodExtended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Presentation of multivariate data for clinical use: The Framingham Study risk score functions
Sullivan, L. M., Massaro, J. M., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1742 · Cited by 1,753 · cited 1×
“half of the smallest coefficient and rounding to the nearest integer (28).”
BackgroundClinical Prediction Rules: Applications and Methodological Standards
Wasson, J. H., Sox, H. C., Neff, R. K., & Goldman, L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509263131306 · Cited by 1,357
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271 · cited 1×
“In the last 2 decades, intensive use of broad-spectrum cephalosporins has led to the emergence of antibiotic-resistant strains of Enterobacteriaceae (predominantly Klebsiella pneumoniae and Escherichia coli) that produce extended-spectrum -lactamases (ESBLs) (8, 12, 20, 21, 27).”
BackgroundIncreasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 799 · cited 1×
“These strains are widespread throughout the world, but the prevalence and phenotypic characteristics of clinical isolates varies from area to area (7, 9).”
BackgroundLaupacis, A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540300056034 · Cited by 793 · cited 1×
“This type of risk stratification has proved to be an important strategy for improving clinical decisions and infection control (11, 13, 17, 29, 30).”
BackgroundSchwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626 · cited 1×
“Failure to provide adequate treatment in the initial stages of bloodstream infections caused by ESBL-producing Enterobacteriaceae has already been linked to a markedly increased risk of mortality (26, 31).”
BackgroundClinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
Giske, C. G., Monnet, D. L., Cars, O., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01169-07 · Cited by 610 · cited 2×
“Several studies suggest that infections caused by ESBL-producing bacteria have an important clinical impact, and the increasing prevalence of these organisms in hospitals has been well documented (9, 12, 34).”
BackgroundBen‐Ami, R., Rodríguez‐Baño, J., Arslan, H., Pitout, J. D. D., Quentin, C., Calbo, E. S., Azap, Ö. K., Arpin, C., Pascual, A., Livermore, D. M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604713 · Cited by 462
Cited by
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Averbuch, D., Orasch, C., Cordonnier, C., Livermore, D. M., Mikulska, M., Viscoli, C., Gyssens, I. C., Kern, W. V., Klyasova, G., Marchetti, O., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.091025 · Cited by 632
Escherichia coli: an old friend with new tidings
Vila, J., Sáez-López, E., Johnson, J. R., Römling, U., Dobrindt, U., Cantón, R., Giske, C. G., Naas, T., Carattoli, A., Martínez-Medina, M., et al. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw005 · Cited by 335
Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D. A., Otter, J. A., & Wilson, A. P. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky027 · Cited by 334
Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen
(2012) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-012-1549-5 · Cited by 326
Rettedal, S., Löhr, I. H., Bernhoff, E., Natås, O. B., Sundsfjord, A., & Øymar, K. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.82 · Cited by 66
Rottier, W. C., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van der Linden, P. D., Ammerlaan, H. S. M., & Bonten, M. J. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ121 · Cited by 61
Rottier, W. C., van Werkhoven, C. H., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van de Garde, E. M., van Hees, B. C., Kluytmans, J. A. J. W., Kuck, E. M., van der Linden, P. D., Prins, J. M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.03.023 · Cited by 22
Metadata
- Authors
- Tumbarello, M., Trecarichi, E. M., Bassetti, M., De Rosa, F. G., Spanu, T., Di Meco, E., Losito, A. R., Parisini, A., Pagani, N., & Cauda, R.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-07
- Volume
- 55
- Issue
- 7
- Pages
- 3485-3490
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2140040366
- Cited by
- 159
- References
- 33
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.